{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:32:02Z","timestamp":1791725522470,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-168948"],"award-info":[{"award-number":["PJT-168948"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008572","name":"University of Ottawa","doi-asserted-by":"publisher","award":["SCR_021845"],"award-info":[{"award-number":["SCR_021845"]}],"id":[{"id":"10.13039\/100008572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008572","name":"University of Ottawa","doi-asserted-by":"publisher","award":["SCR_022882"],"award-info":[{"award-number":["SCR_022882"]}],"id":[{"id":"10.13039\/100008572","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neuropharm.2024.110132","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T08:51:43Z","timestamp":1724748703000},"page":"110132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Rapid reorganization of serotonin projections and antidepressant response to 5-HT1A-biased agonist NLX-101 in fluoxetine-resistant cF1ko mice"],"prefix":"10.1016","volume":"261","author":[{"given":"Faranak","family":"Vahid-Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Newman-Tancredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Francisco","family":"Fuentes-Alvarenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Daigle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1809-3554","authenticated-orcid":false,"given":"Paul R.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110132_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109832","article-title":"Activation of 5-HT1A postsynaptic receptors by NLX-101 results in functional recovery and an increase in neuroplasticity in mice with brain ischemia","volume":"99","author":"Aguiar","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2024.110132_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biochi.2018.10.015","article-title":"The 5-HT1A receptor: signaling to behavior","volume":"161","author":"Albert","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.neuropharm.2024.110132_bib3","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1017\/S1461145709991222","article-title":"F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity","volume":"13","author":"Assie","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2024.110132_bib4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0306-4522(02)00289-0","article-title":"Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide","volume":"114","author":"Austin","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110132_bib66","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00429-016-1278-x","article-title":"Mapping the connectivity of serotonin transporter immunoreactive axons to excitatory and inhibitory neurochemical synapses in the mouse limbic brain","volume":"222","author":"Belmer","year":"2017","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.neuropharm.2024.110132_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0893-133X(96)00242-4","article-title":"Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response","volume":"16","author":"Blier","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.110132_bib6","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2012.0536","article-title":"Serotonin and beyond: therapeutics for major depression","volume":"368","author":"Blier","year":"2013","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110132_bib7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/FBP.0000000000000659","article-title":"Discriminative stimulus properties of the 5-HT1A receptor biased agonists NLX-101 and F13714, in rats trained to discriminate 8-OH-DPAT from saline","volume":"32","author":"Broadbear","year":"2021","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110132_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ph15030337","article-title":"Molecular signaling mechanisms for the antidepressant effects of NLX-101, a selective cortical 5-HT(1A) receptor biased agonist","volume":"15","author":"Cabanu","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2024.110132_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1146\/annurev.cellbio.24.110707.175235","article-title":"Communication between the synapse and the nucleus in neuronal development, plasticity, and disease","volume":"24","author":"Cohen","year":"2008","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2024.110132_bib10","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","author":"Collaborators","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2024.110132_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","author":"Collaborators","year":"2022","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110132_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113082","article-title":"NLX-101, a highly selective 5-HT(1A) receptor biased agonist, mediates antidepressant-like activity in rats via prefrontal cortex 5-HT(1A) receptors","volume":"401","author":"Depoort\u00e8re","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110132_bib13","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1021\/acschemneuro.8b00661","article-title":"Serotonin 5-HT1A receptor biased agonists display differential anxiolytic activity in a rat social interaction model","volume":"10","author":"Depoortere","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110132_bib14","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1177\/0269881119860666","article-title":"Cortical 5-hydroxytryptamine 1A receptor biased agonist, NLX-101, displays rapid-acting antidepressant-like properties in the rat chronic mild stress model","volume":"33","author":"Depoortere","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2024.110132_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2024.110132_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s002130050391","article-title":"PET-characterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brain","volume":"133","author":"Farde","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2024.110132_bib68","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fncir.2013.00153","article-title":"A method for the three-dimensional reconstruction of Neurobiotin-filled neurons and the location of their synaptic inputs","volume":"7","author":"Fogarty","year":"2013","journal-title":"Front Neural Circuits"},{"key":"10.1016\/j.neuropharm.2024.110132_bib17","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/s41386-020-0705-0","article-title":"Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT(1A) receptor stimulation","volume":"45","author":"Fukumoto","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.110132_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/ijnp\/pyx116","article-title":"Role of 5-ht1a receptor stimulation in the medial prefrontal cortex in the sustained antidepressant effects of ketamine","volume":"21","author":"Fukumoto","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2024.110132_bib19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF02311184","article-title":"Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects","volume":"120","author":"Gelfin","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2024.110132_bib20","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00213-021-05849-0","article-title":"The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress","volume":"238","author":"Gluch-Lutwin","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2024.110132_bib21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/416396a","article-title":"Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult","volume":"416","author":"Gross","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2024.110132_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110132_bib23","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0444-22.2023","article-title":"Chronic treatment with serotonin selective reuptake inhibitors does not affect regrowth of serotonin axons following amphetamine injury in the mouse forebrain","volume":"11","author":"Janowitz","year":"2024","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2024.110132_bib24","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1021\/acschemneuro.7b00443","article-title":"Activity of serotonin 5-ht1a receptor biased agonists in rat: anxiolytic and antidepressant-like properties","volume":"9","author":"Jastrzebska-Wiesek","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110132_bib25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.neuron.2016.07.024","article-title":"Regrowth of serotonin axons in the adult mouse brain following injury","volume":"91","author":"Jin","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110132_bib67","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1152\/jn.00824.2014","article-title":"Structural and functional characterization of dendritic arbors and GABAergic synaptic inputs on interneurons and principal cells in the rat basolateral amygdala","volume":"114","author":"Klenowski","year":"2015","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neuropharm.2024.110132_bib26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0091-3057(88)90192-X","article-title":"5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone","volume":"29","author":"Koenig","year":"1988","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2024.110132_bib27","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1021\/acschemneuro.8b00584","article-title":"Serotonin 5-ht1a receptor biased agonists induce different cerebral metabolic responses: a [(18)F]-Fluorodesoxyglucose positron emission tomography study in conscious and anesthetized rats","volume":"10","author":"Levigoureux","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110132_bib28","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1476-5381.2010.00738.x","article-title":"Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors","volume":"160","author":"Llado-Pelfort","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110132_bib29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1369\/00221554211033239","article-title":"Background-free detection of mouse antibodies on mouse tissue by anti-isotype secondary antibodies","volume":"69","author":"Mascadri","year":"2021","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.neuropharm.2024.110132_bib30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1017\/S0033291713001475","article-title":"Somatodendritic 5-hydroxytryptamine1A (5-HT1A) autoreceptor function in major depression as assessed using the shift in electroencephalographic frequency spectrum with buspirone","volume":"44","author":"McAllister-Williams","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2024.110132_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pscychresns.2018.04.002","article-title":"Higher 5-HT1A autoreceptor binding as an endophenotype for major depressive disorder identified in high risk offspring - a pilot study","volume":"276","author":"Milak","year":"2018","journal-title":"Psychiatry Res. Neuroimaging."},{"key":"10.1016\/j.neuropharm.2024.110132_bib32","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.biopsych.2013.03.021","article-title":"Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder","volume":"74","author":"Miller","year":"2013","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110132_bib33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.ne.14.030191.002225","article-title":"Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun","volume":"14","author":"Morgan","year":"1991","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110132_bib34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00429-014-0924-4","article-title":"Conditional anterograde tracing reveals distinct targeting of individual serotonin cell groups (B5-B9) to the forebrain and brainstem","volume":"221","author":"Muzerelle","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2024.110132_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.103937","article-title":"Gepirone-the latest antidepressant on market state-of-the-art or run-of-the-mill?","volume":"94","author":"Naguy","year":"2024","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.neuropharm.2024.110132_bib36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00213-006-0507-z","article-title":"An increased hypothermic response to buspirone in patients with major depression","volume":"188","author":"Navin\u00e9s","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2024.110132_bib37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.psyneuen.2007.01.006","article-title":"Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response","volume":"32","author":"Navines","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2024.110132_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107937","article-title":"Translating biased agonists from molecules to medications: serotonin 5-HT(1A) receptor functional selectivity for CNS disorders","volume":"229","author":"Newman-Tancredi","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2024.110132_bib39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1476-5381.2008.00001.x","article-title":"Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist","volume":"156","author":"Newman-Tancredi","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110132_bib40","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/cercor\/bhw009","article-title":"Cc2d1a loss of function disrupts functional and morphological development in forebrain neurons leading to cognitive and social deficits","volume":"27","author":"Oaks","year":"2017","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2024.110132_bib41","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1007\/s00213-023-06389-5","article-title":"The 5-HT(1A) receptor biased agonists, NLX-204 and NLX-101, display ketamine-like RAAD and anti-TRD activities in rat CMS models","volume":"240","author":"Papp","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2024.110132_bib42","article-title":"The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms","volume":"2698811241254832","author":"Papp","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2024.110132_bib43","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0376-16.2017","article-title":"Perturbation of serotonin homeostasis during adulthood affects serotonergic neuronal circuitry","volume":"4","author":"Pratelli","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2024.110132_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuroscience.2017.07.006","article-title":"Length of axons expressing the serotonin transporter in orbitofrontal cortex is lower with age in depression","volume":"359","author":"Rajkowska","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110132_bib45","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1038\/sj.npp.1301088","article-title":"Temperature regulation in depression: functional 5HT1A receptor adaptation differentiates antidepressant response","volume":"31","author":"Rausch","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.110132_bib46","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1523\/JNEUROSCI.5836-10.2011","article-title":"Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety","volume":"31","author":"Richardson-Jones","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110132_bib47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neulet.2005.12.021","article-title":"5-HT1A receptor activation counteracts c-Fos immunoreactivity induced in serotonin neurons of the raphe nuclei after immobilization stress in the male rat","volume":"397","author":"Rioja","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2024.110132_bib48","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/nn.4116","article-title":"5-HT1A receptors on mature dentate gyrus granule cells are critical for the antidepressant response","volume":"18","author":"Samuels","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110132_bib49","first-page":"33","article-title":"Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms","volume":"192","author":"Sanders-Bush","year":"1975","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.110132_bib50","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF00171331","article-title":"Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo","volume":"348","author":"Sharp","year":"1993","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110132_bib51","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression","volume":"354","author":"Trivedi","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2024.110132_bib52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110132_bib53","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1523\/JNEUROSCI.0352-18.2018","article-title":"Loss of adult 5-ht1a autoreceptors results in a paradoxical anxiogenic response to antidepressant treatment","volume":"39","author":"Turcotte-Cardin","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110132_bib54","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s13311-017-0590-3","article-title":"Chronic fluoxetine induces activity changes in recovery from poststroke anxiety, depression, and cognitive impairment","volume":"15","author":"Vahid-Ansari","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2024.110132_bib55","doi-asserted-by":"crossref","first-page":"11967","DOI":"10.1523\/JNEUROSCI.1668-17.2017","article-title":"Abrogated freud-1\/Cc2d1a repression of 5-HT1A autoreceptors induces fluoxetine-resistant anxiety\/depression-like behavior","volume":"37","author":"Vahid-Ansari","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110132_bib56","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1147-23.2023","article-title":"Chronic desipramine reverses deficits in cell activity, norepinephrine innervation, and anxiety-depression phenotypes in fluoxetine-resistant cF1ko mice","volume":"44","author":"Vahid-Ansari","year":"2024","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110132_bib57","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fnins.2019.00404","article-title":"Overcoming resistance to selective serotonin reuptake inhibitors: targeting serotonin, serotonin-1A receptors and adult neuroplasticity","volume":"13","author":"Vahid-Ansari","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110132_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2022.103719","article-title":"Biased 5-HT(1A) receptor agonists F13714 and NLX-101 differentially affect pattern separation and neuronal plasticity in rats after acute and chronic treatment","volume":"120","author":"van Hagen","year":"2022","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110132_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107867","article-title":"Pharmacological MRI to investigate the functional selectivity of 5-HT1A receptor biased agonists","volume":"172","author":"Vidal","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110132_bib60","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1038\/s41386-018-0145-2","article-title":"In vivo biased agonism at 5-HT1A receptors: characterisation by simultaneous PET\/MR imaging","volume":"43","author":"Vidal","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.110132_bib61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature11617","article-title":"A prefrontal cortex-brainstem neuronal projection that controls response to behavioural challenge","volume":"492","author":"Warden","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2024.110132_bib62","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1113\/JP282088","article-title":"Serotonin activates paraventricular thalamic neurons through direct depolarization and indirect disinhibition from zona incerta","volume":"599","author":"Ye","year":"2021","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2024.110132_bib63","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41398-020-01008-9","article-title":"Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression","volume":"10","author":"Zahrai","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2024.110132_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111824","article-title":"A paraventricular thalamus to central amygdala neural circuit modulates acute stress-induced heightened wakefulness","volume":"41","author":"Zhao","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2024.110132_bib65","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1471-4159.2005.03562.x","article-title":"Evidence that serotonin reuptake modulators increase the density of serotonin innervation in the forebrain","volume":"96","author":"Zhou","year":"2006","journal-title":"J. Neurochem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T03:56:39Z","timestamp":1730865399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824003010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":68,"alternative-id":["S0028390824003010"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110132","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid reorganization of serotonin projections and antidepressant response to 5-HT1A-biased agonist NLX-101 in fluoxetine-resistant cF1ko mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110132"}}